- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01941433
Arthritis Health Journal Proof of Concept Study (AHJ)
June 27, 2018 updated by: Diane Lacaille, University of British Columbia
Proof of Concept Study of the Arthritis Health Journal, a Patient Passport for Rheumatoid Arthritis
The purpose of this study is to determine whether an online patient passport tool called the Arthritis Health Journal can assist people with rheumatoid arthritis in managing their disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patient passports have been developed and used in chronic diseases, such as diabetes, to promote active involvement of patients in their care, and have led to better treatment and health outcomes.
In rheumatoid arthritis (RA), active involvement of patients in monitoring their symptoms and their disease activity may facilitate treatment according to current recommendations, which emphasize the need for aggressive treatment to suppress inflammation and for using a "Treat to Target" approach where treatment is escalated until a target is reached and is promptly modified when target is no longer met.
In this study, the investigators have developed an online tool that aims to help people with RA monitor their symptoms and their disease activity and self-manage their arthritis.
The investigators will perform a proof of concept study assessing how the Arthritis Health Journal affects consumer effectiveness, patient self-efficacy, communication with health professionals, shared decision-making, and satisfaction with medical care.
The investigators will also evaluate the feasibility and satisfaction with using the Arthritis Health Journal.
The investigators will use a stepped wedge study design, in which 50 participants will be randomized to either the intervention group (immediate use of the Arthritis Health Journal) or the control group (waitlisted for 6 months).
Due to the nature of the intervention, the study is not blinded.
Study Type
Interventional
Enrollment (Actual)
95
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
British Columbia
-
Richmond, British Columbia, Canada, V6X 2C7
- Arthritis Research Centre of Canada
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be 18 years of age or older
- Have a diagnosis of rheumatoid arthritis
- Be under the ongoing care of a rheumatologist
- Be comfortable using a computer and online applications
- Have access to an Internet connection
- Be able to read and write English without needing a translator
Exclusion Criteria:
- Younger than 18 years of age;
- Diagnoses of arthritis other than rheumatoid arthritis
- not under the ongoing care of a rheumatologist
- not comfortable using a computer
- lack of Internet access
- inability to read and write in English without a translator
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Arthritis Health Journal
Participants in this group will use the Arthritis Health Journal in the first 6 months of study.
|
|
|
Other: Control
Participants in this group will receive a delayed intervention.
They will receive usual care for the first 6 months of study, during which time they will contribute control data, and they will use the Arthritis Health Journal in the second 6 months of study, during which time they will contribute intervention data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Management Behaviours
Time Frame: 6 months
|
We will use the overall score from the Partners in Health Scale, an 11 item questionnaire based on the principles of self-management, which measures people's ability to engage in behaviours for the self-management of a chronic disease.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-Efficacy
Time Frame: 6 months
|
We will use the Stanford Self-Efficacy Scale to measure patient's confidence in their ability to perform certain actions to manage their disease and cope with the consequences of their disease.
Specifically we will include the "Manage Arthritis Symptoms", "Manage Disease in General", and "Communicate with Physician" subscales.
|
6 months
|
|
Consumer Effectiveness
Time Frame: 6 months
|
We will use the Effective Consumer (EC-17) scale to measure patient's ability to deal with a chronic condition and make decisions about their health care.
We will use the global EC-17 score, as well as results to individual questions (6, 7, 9, and 13) which were selected for their relevance to our intervention.
|
6 months
|
|
Patient Satisfaction with Care
Time Frame: 6 months
|
We will use the Patient Satisfaction Questionnaire to measure satisfaction with care and patient-physician interactions.
|
6 months
|
|
Self-Management Behaviours
Time Frame: 6 months
|
We will measure the results of individual questions 7 to 11 from the Partners in Health Scale, which specifically measure involvement in aspects of care relevant to our intervention.
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Diane Lacaille, MD MHSc, Arthritis Research Centre of Canada
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (Actual)
January 1, 2015
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
September 10, 2013
First Submitted That Met QC Criteria
September 12, 2013
First Posted (Estimate)
September 13, 2013
Study Record Updates
Last Update Posted (Actual)
June 29, 2018
Last Update Submitted That Met QC Criteria
June 27, 2018
Last Verified
June 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H12-00691
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
Yuanyuan ZhangRecruitingRheumatoid Arthritis (RA) | Rheumatoid Arthritis-Associated Interstitial Lung Disease | Difficult-to-Treat Rheumatoid ArthritisChina
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
University Hospital, ToulouseCompletedRheumatoId ArthritisFrance
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
-
David Grant U.S. Air Force Medical CenterCompleted
Clinical Trials on Arthritis Health Journal
-
Agency for Healthcare Research and Quality (AHRQ)Unknown
-
Milton S. Hershey Medical CenterFirst Affiliated Hospital of Heilongjiang Chinese Medicine UniversityCompleted
-
University of OttawaUnknown
-
Bambino Gesù Children's Hospital IRCCSMinistry of Health, ItalyRecruitingDepression | Anxiety | Post Traumatic Stress Disorder | Narrative Medicine | Post Intensive Care SyndromeItaly
-
Michigan State UniversityKenyan Diabetes Management & Information Centre (DMI)CompletedType 1 DiabetesKenya
-
Wayne State UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Completed
-
St George Hospital, AustraliaNational Health and Medical Research Council, Australia; The University of... and other collaboratorsUnknownPersonal Health Records | Chronic Medical Conditions | Electronic Medical RecordAustralia
-
University of Wisconsin, MadisonNot yet recruitingAdolescent Behavior | Social MediaUnited States
-
University Hospital, MontpellierUnknown
-
Centre Hospitalier St AnneDirection Générale de l'Offre de SoinsRecruiting